BIOPEP-UWM: Report
| ID | 10631 |
| Name | Glutamate carboxypeptidase II inhibitor |
| sequence |
| Function: | |||
| Inhibitor of Glutamate carboxypeptidase II (EC 3.4.17.21) (MEROPS ID: M28.010) | |||
| Number of residues | 3 |
Activity code | gluc2 |
| Activity : | glutamate carboxypeptidase II inhibitor |
|||
| Chemical mass | 304.2527 | Monoisotopic mass | 304.0902 | |
| IC50 : | 0.00 µM |
|||
| Bibliographic data: | |
| Authors | |
| Robinson M. B., Blakely R. D., Couto R., Coyle J. T | |
| Title | |
| Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. J. Biol. Chem., 262, 14498-14506, 1987 | |
| Year | Source |
| 1987 | Journal |
| Additional information: |
| BIOPEP-UWM database of bioactive peptides SMILES: CC(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)O InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1 InChIKey=OPVPGKGADVGKTG-BQBZGAKWSA-N {C2:0} - Acetic acid - N-terminal modification (ID 130 in the BIOPEP-UWM repository of amino acids and modifications) |
| Database reference: |
| BindingDB: ID 17658 BRENDA: Ligand N-Acetyl-Asp-Glu CAS: Registry No 3106-85-2 ChEBI: ID 73688 ChEMBL: ID CHEMBL1329032 ChemSpider: ID 164080 Clinical Trials: compound ISOSPAGLUMIC ACID DrugBank: ID DB08835 ECHA: ID 635-744-0 EPA CompTox: ID DTXSID3091535 FDA SRS: 1W8M12WXYL FooDB: ID FDB022406 Guide to Pharmacology: ID 1405 HMDB: ID HMDB0001067 J-GLOBAL: ID 200907064777600204 KEGG: ID C12270 MarkerDB: ID MDB00029994 MedChemExpress: ID HY-100921 Metabolights: ID MTBLC73688 Metabolomics Workbench: ID 67852 Nikkaji: ID J22.752H NSC: ID 758468 PubChem: CID 188803 SureChEMBL: ID SCHEMBL288514 UNII: ID 1W8M12WXYL ZINC: ID ZINC000026648612 |